CVE-2025-2745
AVEVA PI Web API Cross-site Scripting
A cross-site scripting vulnerability exists in AVEVA PI Web API version 2023 SP1 and prior that, if exploited, could allow an authenticated attacker (with privileges to create/update annotations or upload media files) to persist arbitrary JavaScript code that will be executed by users who were socially engineered to disable content security policy protections while rendering annotation attachments from within a web browser.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- High
- Privileges needed
- Low
- User interaction
- Active
What an attacker can affect
- Confidentiality
- None
- Integrity
- None
- Availability
- None
Exploit likelihood
What each source reports
CVE List Score used
AVEVA PI Web API Cross-site Scripting
A cross-site scripting vulnerability exists in AVEVA PI Web API version 2023 SP1 and prior that, if exploited, could allow an authenticated attacker (with privileges to create/update annotations or upload media files) to persist arbitrary JavaScript code that will be executed by users who were socially engineered to disable content security policy protections while rendering annotation attachments from within a web browser.
- Record
CVE-2025-2745- CVSS 4.0
- 4.5 Medium
CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:A/VC:N/VI:N/VA:N/SC:H/SI:L/SA:N - CVSS 3.1
- 6.5 Medium
CVSS:3.1/AV:N/AC:H/PR:L/UI:R/S:C/C:H/I:L/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
EUVDEUVD-2025-18212
A cross-site scripting vulnerability exists in AVEVA PI Web API version 2023 SP1 and prior that, if exploited, could allow an authenticated attacker (with privileges to create/update annotations or upload media files) to persist arbitrary JavaScript code that will be executed by users who were socially engineered to disable content security policy protections while rendering annotation attachments from within a web browser.
- Record
EUVD-2025-18212- CVSS 4.0
- 4.5 Medium
CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:A/VC:N/VI:N/VA:N/SC:H/SI:L/SA:N - Updated
- 2026-11-02
GitHub AdvisoriesGHSA-986q-gcjg-v754
A cross-site scripting vulnerability exists in AVEVA PI Web API version 2023 SP1 and prior that,...
A cross-site scripting vulnerability exists in AVEVA PI Web API version 2023 SP1 and prior that, if exploited, could allow an authenticated attacker (with privileges to create/update annotations or upload media files) to persist arbitrary JavaScript code that will be executed by users who were socially engineered to disable content security policy protections while rendering annotation attachments from within a web browser.
- Record
GHSA-986q-gcjg-v754- CVSS 4.0
- 4.5 Medium
CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:A/VC:N/VI:N/VA:N/SC:H/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X - CVSS 3.1
- 6.5 Medium
CVSS:3.1/AV:N/AC:H/PR:L/UI:R/S:C/C:H/I:L/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
NVD
A cross-site scripting vulnerability exists in AVEVA PI Web API version 2023 SP1 and prior that, if exploited, could allow an authenticated attacker (with privileges to create/update annotations or upload media files) to persist arbitrary JavaScript code that will be executed by users who were socially engineered to disable content security policy protections while rendering annotation attachments from within a web browser.
- Record
CVE-2025-2745- CVSS 4.0
- 4.5 Medium
CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:A/VC:N/VI:N/VA:N/SC:H/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X - CVSS 3.1
- 6.5 Medium
CVSS:3.1/AV:N/AC:H/PR:L/UI:R/S:C/C:H/I:L/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| first indexed | CVE List, EUVD, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2025-2745 is a medium vulnerability (CVSS 4.5) in Aveva Pi Web Api, published June 12, 2025. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.25%, the 16th percentile. No source names a fixed version.